These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1489892)

  • 1. Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
    Kazama Y; Foster DC; Kisiel W
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):697-702. PubMed ID: 1489892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
    Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
    J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
    Yamamoto M; Nakagaki T; Kisiel W
    J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
    Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
    Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
    Bharadwaj D; Iino M; Kontoyianni M; Smith KJ; Foster DC; Kisiel W
    J Biol Chem; 1996 Nov; 271(48):30685-91. PubMed ID: 8940045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1992 Jul; 267(20):14477-82. PubMed ID: 1629232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation.
    Kazama Y; Hamamoto T; Foster DC; Kisiel W
    J Biol Chem; 1995 Jan; 270(1):66-72. PubMed ID: 7814421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells.
    Thim L; Bjoern S; Christensen M; Nicolaisen EM; Lund-Hansen T; Pedersen AH; Hedner U
    Biochemistry; 1988 Oct; 27(20):7785-93. PubMed ID: 3264725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raising the active site of factor VIIa above the membrane surface reduces its procoagulant activity but not factor VII autoactivation.
    Waters EK; Yegneswaran S; Morrissey JH
    J Biol Chem; 2006 Sep; 281(36):26062-8. PubMed ID: 16835245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
    Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.
    Chaing S; Clarke B; Sridhara S; Chu K; Friedman P; VanDusen W; Roberts HR; Blajchman M; Monroe DM; High KA
    Blood; 1994 Jun; 83(12):3524-35. PubMed ID: 8204879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells and the activation of factor VII.
    Rao LV; Rapaport SI
    Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.
    Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ
    J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).
    O'Brien DP; Kemball-Cook G; Hutchinson AM; Martin DM; Johnson DJ; Byfield PG; Takamiya O; Tuddenham EG; McVey JH
    Biochemistry; 1994 Nov; 33(47):14162-9. PubMed ID: 7947828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.